FY2027 EPS Estimates for Revvity Boosted by Leerink Partnrs

Revvity Inc. (NYSE:RVTY) – Analysts at Leerink Partnrs boosted their FY2027 EPS estimates for Revvity in a report released on Wednesday, November 19th. Leerink Partnrs analyst P. Souda now expects that the company will post earnings of $6.09 per share for the year, up from their previous estimate of $6.08. The consensus estimate for Revvity’s current full-year earnings is $4.94 per share.

A number of other equities analysts have also recently weighed in on RVTY. Weiss Ratings reissued a “sell (d)” rating on shares of Revvity in a research note on Wednesday. Stifel Nicolaus decreased their target price on shares of Revvity from $120.00 to $110.00 and set a “hold” rating for the company in a report on Tuesday, July 29th. Wall Street Zen downgraded shares of Revvity from a “buy” rating to a “hold” rating in a research report on Sunday, August 3rd. Bank of America cut their price target on shares of Revvity from $110.00 to $99.00 and set a “buy” rating on the stock in a report on Monday, September 22nd. Finally, Barclays upped their price target on shares of Revvity from $100.00 to $105.00 and gave the company an “overweight” rating in a research report on Tuesday, October 28th. Eight research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $114.75.

Revvity Stock Up 4.3%

Shares of Revvity stock opened at $98.10 on Friday. Revvity has a 12-month low of $81.36 and a 12-month high of $128.29. The firm has a market capitalization of $11.12 billion, a PE ratio of 49.30, a price-to-earnings-growth ratio of 3.15 and a beta of 1.01. The company has a quick ratio of 2.75, a current ratio of 1.75 and a debt-to-equity ratio of 0.36. The stock’s fifty day moving average is $91.43 and its 200-day moving average is $92.28.

Revvity (NYSE:RVTY) last announced its quarterly earnings data on Monday, October 27th. The company reported $1.18 EPS for the quarter, beating analysts’ consensus estimates of $1.14 by $0.04. The company had revenue of $698.95 million during the quarter, compared to the consensus estimate of $699.75 million. Revvity had a return on equity of 7.52% and a net margin of 8.44%.The company’s quarterly revenue was up 2.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.28 EPS. Revvity has set its FY 2025 guidance at 4.900-5.000 EPS.

Revvity declared that its Board of Directors has approved a share repurchase plan on Monday, October 27th that permits the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization permits the company to reacquire up to 8.7% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company’s board of directors believes its stock is undervalued.

Revvity Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 6th. Investors of record on Friday, January 16th will be issued a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a dividend yield of 0.3%. The ex-dividend date is Friday, January 16th. Revvity’s dividend payout ratio (DPR) is currently 14.07%.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in the stock. HB Wealth Management LLC boosted its stake in shares of Revvity by 4.8% during the 1st quarter. HB Wealth Management LLC now owns 2,494 shares of the company’s stock valued at $264,000 after buying an additional 114 shares during the period. First National Advisers LLC increased its stake in shares of Revvity by 0.8% in the third quarter. First National Advisers LLC now owns 15,023 shares of the company’s stock worth $1,317,000 after acquiring an additional 125 shares during the last quarter. Caitong International Asset Management Co. Ltd raised its holdings in shares of Revvity by 25.3% during the first quarter. Caitong International Asset Management Co. Ltd now owns 694 shares of the company’s stock worth $73,000 after acquiring an additional 140 shares in the last quarter. Banque Transatlantique SA boosted its position in Revvity by 19.4% during the first quarter. Banque Transatlantique SA now owns 925 shares of the company’s stock valued at $90,000 after purchasing an additional 150 shares during the last quarter. Finally, Mackenzie Financial Corp boosted its position in Revvity by 1.7% during the third quarter. Mackenzie Financial Corp now owns 8,955 shares of the company’s stock valued at $785,000 after purchasing an additional 154 shares during the last quarter. Institutional investors and hedge funds own 86.65% of the company’s stock.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.